Research Centers for Improving Management of Symptoms During and Following Cancer Treatment (UM1 Research Project with Complex Structure Cooperative Agreement)

Jan 19,2018 | Consortium_staff Funding Opportunities

Posted by: NIH (RFA-CA-17-042)
Post date: October 18, 2017
Open date: December 17, 2017
Letter of Intent (LOI) due date(s): 30 days prior to the application due date
Application due date: January 17, 2018
Expiration date: January 18, 2018

This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative established to accelerate cancer research. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP): the Implementation of Integrated and Evidenced-based Symptom Management Throughout the Cancer Trajectory. The purpose of this specific FOA is to promote research on the implementation and evaluation of integrated symptom monitoring and management systems for use in cancer care delivery through a Research Consortium. This research will provide new insights and valuable evidence that can be used to guide efforts on a nation-wide basis to improve symptom control for cancer patients during treatment and survivorship.

The consortium will consist of three Research Centers (to be supported by this UM1 FOA) and a Coordinating Center (to be funded under a companion U24 FOA, RFA-CA-17-043).

Each Research Center is expected to:

  • Deploy an integrated symptom monitoring and management system in a group of clinical practices, and
  • Test the impact of that system on patient outcomes, cancer treatment delivery, and healthcare utilization using a randomized design.

The Research Centers will be expected to interact with the Coordinating Center and engage in collaborative activities with the entire consortium. Collaborative activities will be supported scientifically and coordinated administratively and logistically by the Coordinating Center.

Read RFA-CA-17-042 for more information.